dc.creatorVitral, C. L.
dc.creatorSouto, F. J. D.
dc.creatorGaspar, A. M. C.
dc.date2019-03-28T15:41:20Z
dc.date2019-03-28T15:41:20Z
dc.date2008
dc.date.accessioned2023-09-26T20:46:48Z
dc.date.available2023-09-26T20:46:48Z
dc.identifierVITRAL, C. L.; SOUTO, F. J. D.; GASPAR, A. M. C. Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy. Journal of Viral Hepatitis, v. 15, Suppl. 2, p. 22-25, 2008.
dc.identifier1352-0504
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/32272
dc.identifier1365-2893
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8863739
dc.descriptionRecent studies have shown that the prevalence of antibody to hepatitis A virus (HAV) is decreasing in several Latin American countries. Brazil is a very large and heterogeneous country, showing striking regional differences. With regard to sanitary facilities, 81.7% of the districts in the south-eastern region have sewage systems, compared with only 5.8% in the northern region. Results of sero-epidemiological studies and reported hepatitis A outbreaks indicate a change in the epidemiological pattern of hepatitis A in the country. Individuals, especially those under the age of 10, are mostly unprotected from HAV infection, regardless of their socioeconomic status. During 2000–2005, approximately 14 000–21 000 cases of hepatitis A were reported annually in Brazil, a rate of 7.5–11 cases per 100 000 population. Nationwide, hepatitis A mortality rates declined progressively from 1980 to 2002. As fatal cases constitute a small, but predictable, portion of all acute hepatitis A cases, which are in turn part of the total number of HAV infections, these data suggest that there has been a decline in HAV circulation in all Brazilian regions over the last two decades. Taken together these facts point out that the epidemiological pattern of hepatitis A is changing in Brazil. Besides improvements in sanitary conditions in the poorest Brazilian regions, the introduction of hepatitis A vaccination of young children could be a strategy for controlling HAV infection in the country.
dc.description2022-01-01
dc.formatapplication/pdf
dc.languageeng
dc.publisherWiley 12 Months
dc.rightsrestricted access
dc.subjectHepatite A
dc.subjectVírus da Hepatite A
dc.subjectEpidemiologia
dc.subjectBrasil
dc.subjectBrazil
dc.subjectEpidemiology
dc.subjectHepatitis A
dc.subjectHepatitis A virus
dc.titleChanging epidemiology of hepatitis A in Brazil: reassessing immunization policy
dc.typeArticle


Este ítem pertenece a la siguiente institución